Molecular Partners presents MP0712 data at upcoming scientific conferences
PUBT · 05/04 05:00
Share
Listen to the news
- Molecular Partners will present data on lead DLL3-targeting Radio-DARPin candidate MP0712 at NIH National Cancer Institute 2026 Small Cell Lung Cancer Consortium Meeting on May 6-7 in Rockville, Maryland.
- Further MP0712 presentations scheduled for PEGS Boston on May 11-15 in Boston, Massachusetts.
- Additional presentation slated for Antibody & Engineering Therapeutics on May 27-29 in Basel, Switzerland.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Molecular Partners AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605040100OMX_____CNEWS_EN_GNW9712026_en) on May 04, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending